Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: The DAMAGE study

European Journal of Human Genetics

Volumn 17, Issue 8, 2009, Pages 1056-1062

  Reiling, Erwin ^a   van Vliet Ostaptchouk, Jana V ^b   van't Riet, Esther ^c   van Haeften, Timon W ^d   Arp, Pascal A ^e   Hansen, Torben ^f   Kremer, Dennis ^a   Groenewoud, Marlous J ^a   van Hove, Els C ^a   Romijn, Johannes A ^a   Smit, Jan W A ^a   Nijpels, Giel ^c   Heine, Robert J ^c   Uitterlinden, André G ^e   Pedersen, Oluf ^f,g,h   Slagboom, P Eline ^a   Maassen, Johannes A ^a,c   Hofker, Marten H ^b   't Hart, Leen M ^a   Dekker, Jacqueline M ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f STENO DIABETES CENTER   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 3; INITIATION FACTOR 2; INITIATION FACTOR 3; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN DARS2; PROTEIN IARS2; PROTEIN MTO1; PROTEIN PPRC1; PROTEIN TARS2; PROTEIN TFAM; PROTEIN TRMU; SIRTUIN 3; SIRTUIN 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOGENESIS; CONTROLLED STUDY; DNA REPLICATION; DNA TRANSCRIPTION; FEMALE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENOME; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL NUCLEUS; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BIOSYNTHESIS;

STENO;

EID: 67749137221     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.4     Document Type: Article

References (47)

1. van den Ouweland JM, Lemkes HH, Ruitenbeek W et al: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-371.
2. Maassen JA, t Hart LM, Janssen GM, Reiling E, Romijn JA, Lemkes HH: Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochem Soc Trans 2006; 34 (Pt 5): 819-823.
3. 't Hart LM, Hansen T, Rietveld I et al: Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 2005; 54: 1892-1895.
4. Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-2950.
5. Mootha VK, Lindgren CM, Eriksson KF et al: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
6. Calvo S, Jain M, Xie X et al: Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 2006; 38: 576-582.
7. Mohlke KL, Jackson AU, Scott LJ et al: Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet 2005; 118: 245-254.
8. Saxena R, de Bakker PI, Singer K et al: Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 2006; 79: 54-61.
9. McCarthy MI: Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 2003; 3: 159-167.
10. Wilson FH, Hariri A, Farhi A et al: A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306 1190-1194.
11. Liao HX, Spremulli LL: Identification and initial characterization of translational initiation factor 2 from bovine mitochondria. J Biol Chem 1990; 265: 13618-13622.
12. Koc EC, Spremulli LL: Identification of mammalian mitochondrial translational initiation factor 3 and examination of its role in initiation complex formation with natural mRNAs. J Biol Chem 2002; 277: 35541-35549.
13. Abahuni N, Gispert S, Bauer P et al: Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease. Neurosci Lett 2007; 414: 126-129.
14. Scheper GC, vanPder Knaap MS, Proud CG: Translation matters: protein synthesis defects in inherited disease. Nat Rev Genet 2007; 8 711-723.
15. Li R, Li X, Yan Q, Qin MJ, Guan MX: Identification and characterization of mouse MTO1 gene related to mitochondrial tRNA modification. Biochim Biophys Acta 2003; 1629 (1-3): 53-59.
16. Umeda N, Suzuki T, Yukawa M et al: Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J Biol Chem 2005; 280: 1613-1624.
17. Li X, Guan MX: A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol Cell Biol 2002; 22: 7701-7711.
18. Song J, Oh JY, Sung YA, Pak YK, Park KS, Lee HK: Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. Diabetes Care 2001; 24: 865-869.
19. Singh R, Hattersley AT, Harries LW: Reduced peripheral blood mitochondrial DNA content is not a risk factor for Type 2 diabetes. Diabet Med 2007; 24: 784-787.
20. Parisi MA, Clayton DA: Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 1991; 252: 965-969.
21. Ekstrand MI, Falkenberg M, Rantanen A et al: Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet 2004; 13: 935-944.
22. Andersson U, Scarpulla RC: Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 2001; 21: 3738-3749.
23. Shi T, Wang F, Stieren E, Tong Q: SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005; 280: 13560-13567.
24. Argmann C, Auwerx J: Insulin secretion: SIRT4 gets in on the act. Cell 2006; 126: 837-839.
25. Yamamoto H, Schoonjans K, Auwerx J: Sirtuin functions in health and disease. Mol Endocrinol 2007; 21: 1745-1755.
26. Bell RM, Coleman RA: Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem 1980; 49: 459-487.
27. Hammond LE, Neschen S, Romanelli AJ et al: Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J Biol Chem 2005; 280: 25629-25636.
28. The International HapMap Consortium: A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
29. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-1223.
30. Mooy JM, Grootenhuis PA, de VH et al: Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 1995; 18: 1270-1273.
31. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus, Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2: Geneva, in 1999.
32. van 't Riet E, Rijkelijkhuizen JM, Nijpels G, Dekker JM: Limited agreement between HbA1c and glucose in the general Dutch population: The New Hoorn Study. Diabetologia 2008; 51 (Suppl 1): S164, (abstract).
33. van Tilburg JH, Sandkuijl LA, Strengman E et al: A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13. J Clin Endocrinol Metab 2003; 88: 2223-2230.
34. Monsuur AJ, de Bakker PI, Alizadeh BZ et al: Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341-1344.
35. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA: Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403-422.
36. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K: Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 2001; 18: 126-132.
37. Gauderman WJ: Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002; 155: 478-484.
38. The Diabetes Genetics Initiative of the Broad Institute of MIT and Harvard, Lund University and Novartis Institutes for BioMedical Research. et al: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316 1331-1336.
39. Zeggini E, Weedon MN, Lindgren CM et al: Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341.
40. Zeggini E, Scott LJ, Saxena R et al: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40: 638-645.
41. McCarthy MI, Abecasis GR, Cardon LR et al: Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356-369.
42. Sladek R, Rocheleau G, Rung J et al: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885.
43. Scott LJ, Mohlke KL, Bonnycastle LL et al: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345.
44. Ek J, Andersen G, Urhammer SA et al: Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 2001; 44: 2220-2226.
45. Krempler F, Esterbauer H, Weitgasser R et al: A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002; 51: 3331-3335.
46. Barroso I, Luan J, Sandhu MS et al: Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 2006; 49: 501-505.
47. Gable DR, Stephens JW, Cooper JA, Miller GJ, Humphries SE: Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men. Diabetes 2006; 55: 1504-1511.